| Comparative effectiveness of novel nonmonetary incentives to promote HIV testing G Chamie, EM Schaffer, A Ndyabakira, DM Emperador, D Kwarisiima, ... Aids 32 (11), 1443-1451, 2018 | 35 | 2018 |
| Promoting HIV testing by men: a discrete choice experiment to elicit preferences and predict uptake of community-based testing in Uganda EM Schaffer, JM Gonzalez, SB Wheeler, D Kwarisiima, G Chamie, ... Applied Health Economics and Health Policy 18, 413-432, 2020 | 21 | 2020 |
| Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial WZ Wysham, EM Schaffer, T Coles, DR Roque, SB Wheeler, KH Kim Gynecologic oncology 145 (2), 340-345, 2017 | 16 | 2017 |
| Changes over time in patient stated values and treatment preferences regarding aggressive therapies: insights from the DECIDE-LVAD trial CE Knoepke, EL Chaussee, DD Matlock, JS Thompson, CK McIlvennan, ... Medical Decision Making 42 (3), 404-414, 2022 | 11 | 2022 |
| Planning prompts to promote uptake of HIV services among men: a randomised trial in rural Uganda NM Kavanagh, EM Schaffer, A Ndyabakira, K Marson, DV Havlir, ... BMJ global health 5 (11), e003390, 2020 | 10 | 2020 |
| Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer EM Schaffer, EM Basch, GM Schwab, AV Bennett Clinical Trials 18 (4), 408-416, 2021 | 8 | 2021 |
| The association between intimate partner violence and women's distribution and use of HIV self-tests with male partners: evidence from a cohort study in Kenya EM Schaffer, K Agot, H Thirumurthy JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (3), e85-e87, 2017 | 8 | 2017 |
| Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: a cost-effectiveness analysis of the aurelia trial EM Schaffer, TM Coles, WZ Wysham, DR Roque, KH Kim, SB Wheeler Value in Health 18 (7), A461, 2015 | 5 | 2015 |
| Optimizing the TRUNCATE strategy to further improve outcomes from two-month treatment for rifampicin-susceptible tuberculosis: Health economics presentation E Schaffer, K Prem, I Sari, HL Wee, NIJ Paton | | 2023 |
| Engaging Men in HIV Testing: A Discrete Choice Experiment to Elicit Preferences and Predict Uptake of HIV Testing Under Alternative Service Delivery Models in Uganda E Schaffer, JM Gonzalez, SB Wheeler, D Kwarisiima, G Chamie, ... 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Promoting HIV Testing by Men in Uganda: Aligning Policy and Preferences E Schaffer | | 2018 |
| Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial WZ Wysham, EM Schaffer, TM Coles, DR Roque, SB Wheeler, KH Kim Gynecologic Oncology 141, 36, 2016 | | 2016 |
| Design of a randomized controlled trial to evaluate the use of short message service (SMS) to promote retention in care and adherence to antiretroviral therapy in Senegal: the … E Schaffer Graduate Institute of International and Development Studies, 2011 | | 2011 |
| Cost-Effectiveness of Community-Based Testing to Increase HIV Diagnosis Among Ugandan Men E Schaffer, S Wheeler, R Su, A Ndyabakira, G Chamie, H Thirumurthy Available at SSRN 5030160, 0 | | |
| Effect of incentivizing men for HIV testing on the HIV testing behavior of women in rural Uganda DM Emperador, A Ndyabakira, E Schaffer, D Kwarisiima, CS Camlin, ... | | |
